Does Dr. IVAN BRANDO AGUILERA have financial conflicts of interest?

Dr. IVAN BRANDO AGUILERA (D.P.M.) has received a total of $6,314 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $6,314 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. IVAN BRANDO AGUILERA?

According to CMS Open Payments data, Dr. IVAN BRANDO AGUILERA received funding from SMITH+NEPHEW ($1,650), ABBVIE ($749), and MIMEDX GROUP ($593).

Does Dr. IVAN BRANDO AGUILERA receive research grants or speaking fees?

Dr. IVAN BRANDO AGUILERA has received $6,314 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. IVAN BRANDO AGUILERA

D.P.M.Real-Time Hydrated

Specialty: Podiatrist, Foot & Ankle Surgery

Practice Location: RIVERSIDE, CA 92507

NPI Number: 1861834178

LIFETIME INDUSTRY VALUE

$6,314

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AGUILERA is a verified Podiatrist, Foot & Ankle Surgery practitioner based in RIVERSIDE, CA.

Between 2021 and 2025, Dr. AGUILERA had an overall industry promotional and research financial footprint of $6,314 as recorded in the federal CMS Open Payments database.

$6,314 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AGUILERA's primary funding source is SMITH+NEPHEW, which accounts for $1,650 (representing 26.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

SMITH+NEPHEW

Rank 1

$1,650

26.1%

ABBVIE

Rank 2

$749

11.9%

MIMEDX GROUP

Rank 3

$593

9.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.